Clinical trial
Embryonic Dopamine Cell Implants for Parkinson's Disease
NCT00038116 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00038116 |
|---|---|
| Title | Embryonic Dopamine Cell Implants for Parkinson's Disease |
| Official title | Embryonic Dopamine Cell Implants for Parkinson's Disease: A Double-Blind Study |
| Lead sponsor | University of Colorado, Denver, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Procedure |
| Interventions | embryonic dopamine cell implant surgery, placebo |
| Enrollment | 40 |
| Start date | May 1, 1995 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | May 30, 2002 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: